Enanta Pharmaceuticals (ENTA) Receivables - Other (2012 - 2015)
Enanta Pharmaceuticals (ENTA) posted Receivables - Other of $1.0 million for Q4 2015, up 133.03% on a QoQ basis from $433000.0 in Q3 2015, and down 46.39% year-over-year from $1.9 million in Q4 2014.
Enanta Pharmaceuticals (ENTA) Receivables - Other (2012 - 2015) Analysis & Trends
Enanta Pharmaceuticals' Receivables - Other history runs 4 years deep, the most recent figure standing at $1.0 million for Q4 2015.
- Quarterly Receivables - Other fell 46.39% year-over-year to $1.0 million in Q4 2015, while the trailing twelve-month figure through Dec 2015 was $1.0 million (down 46.39% YoY) and the FY2015 annual result came in at $433000.0, down 84.37% from the prior year.
- Receivables - Other was $1.0 million for Q4 2015 at Enanta Pharmaceuticals, up from $433000.0 in the prior quarter.
- Across five years, Receivables - Other topped out at $2.8 million in Q3 2014 and bottomed at $433000.0 in Q3 2015.
- A 4-year average of $1.4 million and a median of $1.4 million in 2015 frame the typical range for Receivables - Other.
- Annual changes were most pronounced in 2014 — Receivables - Other jumped 253.32% — and 2015, when it plunged 84.37%.
- Enanta Pharmaceuticals' Receivables - Other stood at $1.7 million in 2012, then plunged by 44.3% to $929000.0 in 2013, then soared by 102.58% to $1.9 million in 2014, then slumped by 46.39% to $1.0 million in 2015.
- Business Quant data shows ENTA's Receivables - Other at $1.0 million in Q4 2015, $433000.0 in Q3 2015, and $1.4 million in Q2 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Enanta Pharmaceuticals | 376.07 Mn | 212.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2015 | 1.01 Mn |
| Dec 31, 2015 | 1.01 Mn |
| Sep 30, 2015 | 433,000.00 |
| Sep 30, 2015 | 433,000.00 |
| Jun 30, 2015 | 1.38 Mn |
| Jun 30, 2015 | 1.38 Mn |
| Mar 31, 2015 | 1.55 Mn |
| Mar 31, 2015 | 1.55 Mn |
| Dec 31, 2014 | 1.88 Mn |
| Dec 31, 2014 | 1.88 Mn |
| Sep 30, 2014 | 2.77 Mn |
| Sep 30, 2014 | 2.77 Mn |
| Jun 30, 2014 | 2.26 Mn |
| Jun 30, 2014 | 2.26 Mn |
| Mar 31, 2014 | 1.60 Mn |
| Mar 31, 2014 | 1.60 Mn |
| Dec 31, 2013 | 929,000.00 |
| Dec 31, 2013 | 929,000.00 |
| Sep 30, 2013 | 784,000.00 |
| Sep 30, 2013 | 784,000.00 |